fda warning bpc-157 not approved safety risks regulatory status for human use The U.S. Food and Drug Administration Doctor explains the craze around

The condition affects roughly 1 to 3% of the general adult population, with peak incidence occurring between ages 30 and 50

N.J.Murray, M.P.Williamson, Conformational study of a salivary proline-rich protein repeat sequence, Eur.J.Biochem., 1993

it is an accurate description of where the science stands

By strengthening the communication between the eyes and the brain, vision therapy aims to help autistic individuals see, process, and respond to the world in a more comfortable way

Cold chain shipping available for temperature-sensitive products

Learn more about BPC-157 therapy and how it may support your recovery goals